Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

NCT05605964 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Relugolix
DRUG: Leuprolide Acetate

Sponsor

Sumitomo Pharma America, Inc.